Subhasri Bandyopadhyay

I am a Medical Professional with substantial experience in Patient Safety and ADR monitoring regularly performing internal and external audit in a cancer hospital. 27 plus years of experience in Indian pharmaceutical market, on a personal drive to add value to business by innovative differentiation using collective and individual strengths/expertise of team members to ensure customer focused plan implementation and deliver scientifically oriented objectives to aid business partners. Industrial liaison person in pharmaceutical market providing marketing inputs generating data for pharmacovigilance and patient safety.

• 01/01/24, Present, Senior Advisor Patient Safety & Pharmacovigilance, NCRI Kolkata
• 01/01/11, 12/31/23, Medical Head, Albert David Ltd
• 01/01/96, 12/31/11, Medical Adviser, Albert David Ltd
• 01/01/92, 12/31/95, Senior Resident, Dept of Pharmacology, IMS, BHU
• 01/01/88, 12/31/91, Junior Resident/ House staff, Dept of Medicine, Dept of Cardiology, Dept of Psychiatry, R G Kar Medical College Kolkata

• Teaching the undergraduates during 3 years of PG
• Teaching the Medical Liasoning Personnel at ADL-Research based teaching (Human Placental Peptides & Nucleotides)
• Teaching Undergraduates in MBBS
• Teaching the Nursing staff
• Teaching the Technician staffs

• Thesis submission during the three years(3) research works in the tenure of Post graduate training in the Department of Pharmacology, IMS, BHU., Gastric Pharmacology, Effects of Omeprazole on mucosal defensive factors.
• The 35th Annual Conference of the Indian Society of Gastroenterology, 1994, Is a potent antiulcer drug Tamrabhasma (An ayurvedic preparations of Copper a safe Drug?), S.Bhattacharyya, R.N.Maity, R.K.Goel, The 35th Annual Conference of the Indian Society of Gastroenterology, 1994, Effect of prolonged administration of Omeprazole on gastric mucosal offensive and defensive factors in rats., R.N.Maity, S.Bhattacharyya, R.K.Goel
• ASOMPS IX ’98, Hanoi, Vietnam, Wound healing activities of human Placental Extract.
• Research on human placental extract with publications

• Published a review article on ‘placental bounty’, IJCP, Oct 2004
• Wound healing activity of human placental extract in rats, Acta Pharmacologica Sinica, 22, 12, 1057-1180
• Human aqueous placental extract as a wound healer, Journal of wound care, 18, 11, 462-467, 2009
• Effect of human placental extract in the management of biofilm mediated drug resistance- focus on wound management, Microbial Pathogenesis, 111, 2017, 307-315

• Trained in GCP and National Ethics guidelines
• Uppsala Medical Centre on Pharmacovigilance

• Specialization: MD PHARMACOLOGY
• Spouse's Name: Dr.M.K.Bandyopadhyay
• Date of Birth: 05/29/63
• Marital Status: Married

Initiated clinical studies on the flagship brand, PLACENTREX, leading to the subsequent publication of the work as part of regulatory requirements

Developed research project through industry academia collaboration along with R& D to widen the indication base of products

Developed the Pharmacovigilance team for the company by training individuals and inducting them to the adverse drug reaction reporting system

Collaborating with R&D for label claim, extension of indication for brands

Collaborating with the Regulatory for labeled indication

Represented the Company to the Thematic Stakeholder Meeting on Access to Essential

Medicines for NTD Geneva, 2009

Developed and implemented project for generation of PSUR data for FDCs with success, saving cost of the company

Developed and implemented protocol for BE studies on Ursodeoxycholic acid for regulatory registration in Philippines successfully, generating revenues for the company